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Abstracts / Osteoarthritis and Cartilage 22 (2014) S1–S6S4Physical activity is a more recent addition to non-pharmaceutical
interventions. In 2008, the US published federal guidelines recom-
mending adults with arthritis participate in 150 minutes of moderate
activity each week accumulated in sessions lasting at least 10 minutes.
Physical activity beneﬁts are supported by dose-response relationships
with better physical function based on longitudinal cohort studies. RCTs
demonstrate the effectiveness of both exercise interventions and
resistance training to improve function and reduce disability in adults
with knee OA. Recent RCTs provide insight into the synergy between
weight loss and physical activity in knee OA. Exercise alone and weight
loss alonewere each effective to improve function; however weight loss
plus exercise had the greatest effect.
These studies support interventions which increase moderate intensity
activity. However, many adults are not candidates to engage in mod-
erate intensity activities due to health limitations. What strategies are
available to these adults? Recent work demonstrated sedentary
behavior is a signiﬁcant risk factor for functional loss in adults including
those with knee OA. Importantly, this relationship is independent of
obesity status and of time spent in moderate intensity activities. These
ﬁndings support replacing sedentary timewith light activity to improve
health outcomes in adults with knee OA who cannot perform/increase
moderate intensity activities.
Taken as a whole, life style interventions provide important strategies
to prevent knee OA and mitigate its consequences. Weight control can
reduce the risk of developing knee OA. For overweight adults with
knee OA, weight loss can effectively improve function. Engaging in
physical activity of moderate intensity can improve function and
reduce disability. Weight loss combined with increased activity pro-
vides added beneﬁts for overweight adults. While the beneﬁts of
physical activity are substantial, not all older adults are candidates to
engage in moderate intensity activities. An alternative strategy is to
replace time spent in sedentary behavior with light intensity activities
to improve function.
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BE IT RESOLVED: PLAIN RADIOGRAPHY OR MRI – WHICH IS BETTER
IN ASSESSING OUTCOME IN CLINICAL TRIALS?
F. Eckstein y, M.-P. Hellio Le Graverand z. y Paracelsus Med. Univ.,
Salzburg, Austria; z Pﬁzer Dev. Japan, Tokyo, Japan
Purpose: Imaging in clinical trials is commonly used to evaluate the
efﬁcacy of a therapeutic intervention, but also for subject eligibility and
safety. The results of clinical trials can support decision making in
DMOAD development, by ascertaining treatment effects on joint
structure, potentially before these translate to clinical beneﬁts. This
debate will focus on the use of radiography and magnetic resonance
imaging (MRI) in research trials and in clinical trials of knee osteo-
arthritis. Depending on the context, the strength and weaknesses of
each imaging technique will be highlighted and performance will be
compared.
Methods: The authors have performed a full-text literature on imaging
of the knee, with a focus on bone and cartilage, adding primary expe-
rience in the implementation of imaging methods in clinical trials, and
results presented at recent conferences.
Results: The authors will present summary data on the reliability
(consistency, test-retest precision) of radiographic measurement of
joint space width (JSW) and cartilage thickness with MRI. They will
address the construct, concurrent and predictive validity of both
methods, compare their sensitivity to change in knee OA in studies that
examined JSW and cartilage thickness change in the same subjects, and
highlight the speciﬁc potential and the limitations of each imaging
technique. Finally, the correlation with clinical outcomes and the
response to treatment will be addressed.
Conclusion: Current imaging methodologies provide powerful tools for
evaluating morphological and compositional aspects of most articular
tissues, capturing longitudinal change with reasonable to excellent
sensitivity. Radiography and MRI are complementary imaging techni-
ques; each has speciﬁc strengths and weaknesses that depend on the
speciﬁc context of the questions asked. When employed properly, each
of them involves potential for ascertaining treatment effects on joint
structure, potentially over shorter time scales than required for dem-
onstrating effects on clinical outcomes.I-11
NON-CARTILAGE CHANGES VISUALIZED BY MRI AND RISK FOR OA
DEVELOPMENT/PROGRESSION
M.D. Crema. Boston Univ., Boston, MA, United States
Non-cartilaginous tissues that may be affected in osteoarthritis (OA)
include the subchondral bone, synovium, ﬁbrocartilage, ligaments and
muscles. Due to its capability to visualize pathology in different tissues
with excellent contrast, magnetic resonance imaging (MRI) provides
high-resolution andmultiplanar assessment of the bone and soft tissues
mentioned above. The use of semiquantitative and quantitative MRI
biomarkers of non-cartilaginous tissues in clinical and epidemiological
OA studies is reviewed. Bone marrow lesions (BMLs) are deﬁned onMRI
as non-cystic subchondral areas of ill-deﬁned hyperintensity on ﬂuid-
sensitive spin-echo sequences, and were shown to be associated with
incidence and progression of knee OA, including progression of MRI-
detected cartilage loss and radiographically detected joint space nar-
rowing (JSN). MRI is the best imaging method for the detection and
grading of BMLs. The close relationship between BMLs and cartilage
damage in the same region of the joint was extensively demonstrated in
previous studies. BMLs represent a highly variable feature in patients
with or at risk for development of knee OA, as their size may increase or
decrease over time. This is of relevance since it was demonstrated that
the ﬂuctuation of BML size over time seems to have a direct effect on
progression of disease assessed on a subregional basis. MRI is also
capable to accurately assess the morphology of the subchondral bone,
especially in the detection of any degree of subchondral ﬂattening or
depression, also known as subchondral bone attrition. A strong asso-
ciation exists between subchondral bone attrition and subchondral
BMLs in the same region of the knee, and the association increases with
BML size. Further, it was demonstrated that attrition represents a risk
factor for progression of cartilage loss in the same compartment of the
knee. Meniscal damage including tears and maceration, as well as
meniscal extrusion, were shown to be independently associated with
incidence and progression of OA, including progression of radio-
graphically-detected JSN and MRI-detected cartilage loss. MRI is the
method of choice in the assessment of meniscal damage and meniscal
extrusion, with multiplanar spin-echo techniques being the most
appropriate for their detection and grading. Although synovitis in OA is
thought to be a secondary phenomenon related to cartilage deterio-
ration, its importance in the OA process is well recognized. Several
methods for detecting and quantifying synovitis with non-enhanced
and contrast-enhanced MRI are available. Synovitis should be ideally
assessed and quantiﬁed using gadolinium-enhanced MRI, although
surrogate markers for synovitis on non-enhanced MRI are available and
are widely utilized in published studies. There is little evidence that
synovitis is not only a secondary phenomenon in patients with knee OA
but may also play a role in progression of disease. This relationship
remains to be demonstrated in large longitudinal studies. Alternatively,
synovitis can be evaluated in combination with effusion on ﬂuid-sen-
sitive sequences but differentiation between inﬂamed synovium and
joint ﬂuid ﬁlling the joint cavity surrounded by synovium may be dif-
ﬁcult. Ligament injury can be accurately depicted by multiplanar MRI
assessment of joints. In the knee, it was demonstrated that cruciate
ligament deﬁciency secondary to tears increase the risk for incidence or
progression of OA. Further, it was shown that collateral ligaments at
both distal and proximal interphalangeal joints may play a role in early
stages of OA. The role of other non-cartilaginous tissues accurately
assessed by MRI, such as the acetabular labrum (hip) and quadriceps
muscle (knee), and their relationship with structural deterioration in
these joints was also demonstrated in a few studies. This presentation
reviews the role of non-cartilage structures, as well as pathology in
these structures, in the development and/or progression of OA, focusing
in the knee joint, based on the evidence in the literature.
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GENETICS/GENOMICS IN OSTEOARTHRITIS
A. Tsezou. Univ. of Thessaly, Faculty of Med., Larissa, Greece
In this year review recent developments in genetics/genomics of
osteoarthritis (OA) are discussed to improve our understanding of OA
pathophysiology. In OA genetics, a meta-analysis of genome wide
association studies (GWAS) revealed novel loci for hip OA, among which
Abstracts / Osteoarthritis and Cartilage 22 (2014) S1–S6 S5a variant near the NCOA3 (nuclear receptor coactivator 3) gene and an
199-candidate gene meta-analysis of GWAS demonstrated association
only between COL11A1 and VEGF genes and hip OA. In addition, the
effect of the FTO variant on OA risk was found to be mediated through
body mass index. In OA genomics, four trans-acting factors were
identiﬁed that bind to GDF5 and regulate its expression via the OA
susceptibility locus rs143383. Gene expression microarray studies in OA
synovium showed elevation of collagens and cross-linking enzymes
(COL1A1, COL5A1, PLOD2, LOX and TIMP1) responsive to TGF-b and also
differential expression pattern between different areas of the osteo-
arthritic synovial membrane. Microarray analysis in peripheral blood
demonstrated differentially expressed genes involved in apoptotic
pathways between OA patients and healthy controls. Furthermore, gene
expression proﬁling in OA subchondral bone revealed differentially
expressed genes involved in cartilage and bone development and OA
pathogenesis. In epigenetics, a number of studies identiﬁed the role of
several microRNAs (miRs) in regulation of gene expression in chon-
drocytes and highlighted their use as potential drug targets. Among
them, miR-125 was implicated in ADAMTS-4 regulation, miR-127b in
MMP-13 regulation and IL-1b induced catabolic effects, miR-1247 was
shown to directly target SOX9 and overexpression of hsa-miR-148a in
OA chondrocytes inhibited hypertrophic differentiation and increased
COL2A1 production. Future studies must focus on the integration of
genetics and genomics for the identiﬁcation of signaling pathways and
regulatory networks responsible for OA development.
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YEAR IN REVIEW - BIOMARKERS IN OA
F.J. Blanco. INIBIC-CHUAC, A Coru~na, Spain
Currently, OA diagnosis is mainly symptomatic, resting on the
description of pain symptoms, stiffness of the affected joints, and
radiography, which has been the reference technique to determine the
grade of joint destruction. This is of key importance, since radiography
provides only indirect information about the joint tissue and it has poor
sensitivity to detect changes. This lack of diagnostic tools is especially
important in OA, since there is currently no effective therapy for this
disease. A major pursue in OA research relies in the deﬁnition of early
diagnostic strategies, which would also aid to enable an accurate
monitoring of the progression of the disease. OA remains silent at its
initial stages in most patients, and there is already an extensive dete-
rioration of cartilage at the time of diagnosis. All this background is the
reason for the substantial interest in ﬁnding new speciﬁc biological
markers of osteoarthritis that will facilitate not only early diagnosis of
joint destruction (which will enable early interventions intended to
slow the progression of the disease), but also disease prognosis or
evolution studies (which will facilitate the development of alternative
therapeutic strategies). Over the years there have been proposed a
series of biochemical markers which may reﬂect the synthesis or deg-
radation of the three main joint tissues (cartilage, synovial membrane
and bone), and this list is continuously expanding. However, despite the
active research in this ﬁeld, no single biomarker stands out as the gold
standard or is sufﬁciently validated and qualiﬁed for its systematic use
in OA diagnosis or anti-OA drug development. The most promising
diagnostic approach would be the study of combinations of biomarkers.
New multiplexed approaches have emerged in the recent years for the
identiﬁcation and veriﬁcation of novel OA biomarkers, employing
genomics, proteomics and metabolomics tools. In this review I will
present the most relevant proteomic and metabolomics results pub-
lished since April 2013 to April 2014 focused in the early and con-
solidated diagnosis of OA, in to predict how it will develop, or respond
to therapy.
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THE YEAR IN REVIEW: REGENERATIVE MEDICINE
G.J. van Osch. Erasmus MC, Rotterdam, Netherlands
Regenerative medicine is an emerging area that will inﬂuence the
treatment of joint diseases in the future. It involves the use of bio-
materials, cell therapy, and bioactive factors such as growth factors,
drugs and small molecules to regenerate damaged tissues. This multi-
disciplinary ﬁeld is extremely active, with rapid development of new
technologies that emerge from basic sciences as well as by the
increasing number of clinical studies of ever increasing quality. Apubmed search revealed over 2000 hits in the past year on regener-
ation/repair of joint tissues (excluding bone regeneration in its own
right) and over 25 new clinical trials on joint regeneration therapies
were registered. This “year in review”will highlight a personal selection
of promising studies in biomaterials, stem cell biology and the trans-
lation from the lab to the clinic published in the past year and will
inform on the direction in which this ﬁeld is moving.
I-15
OSTEOARTHRITIS YEAR 2014 IN REVIEW: CLINICAL
G.A. Hawker. Women’s Coll. Hosp., Toronto, ON, Canada
A systematic literature review was conducted using PubMed for the
period between April 1, 2013 and March 31, 2014. Research articles that
focused on the epidemiology, clinical management - both non-phar-
macologic and pharmacologic - or access to and outcomes of treatment
for people with osteoarthritis were reviewed. Selected articles in these
areas are discussed in this narrative review article.
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OSTEOARTHRITIS YEAR IN REVIEW: REHABILITATION AND
OUTCOMES
M. Maly. McMaster Univ., Hamilton, ON, Canada
Purpose: The purpose of this review will be to highlight research
studies examining rehabilitation for hip and knee osteoarthritis, as well
as the outcomes used to assess treatment effectiveness, published
between January and December 2013.
Methods: A systematic literature was performed in Medline, CIHAHL
and Embase databases from January 1, 2013 to December 12, 2013. Key
words used in the searches included osteoarthritis, knee; osteoarthritis,
hip; rehabilitation; physical therapy modalities; physical therapy;
physiotherapy; and exercise. The search was limited to 2013, human
studies and English. Rehabilitation intervention studies included in the
review were prospective controlled designs that enrolled study par-
ticipants with a diagnosis of knee or hip osteoarthritis. Uncontrolled,
qualitative and retrospective studies, protocols, as well as reviews,
meta-analyses and case studies were excluded. Studies of outcomes
after surgical interventions, oral or injectable medications, and neu-
traceuticals were also excluded. Publication titles and abstracts were
reviewed for inclusion by both authors. Discrepancies for inclusion
were discussed and full papers reviewed to reach agreement on
inclusion. Papers were evaluated for quality of evidence using the
Grading of Recommendations Assessment, Development and Evalua-
tion (GRADE) system by both authors. This system rates the quality of
evidence as high (A), moderate (B), low (C), and very low (D) based on
study limitations, consistency, directness, precision and publication
bias. The authors reached consensus on quality of evidence ratings for
each article.
Results: Of 502 titles reviewed, 36 studies were identiﬁed for inclusion.
Of these 36 papers, only two papers were dedicated to hip OA. Five
studies included participants with both knee and hip OA and 29 studies
included only knee OA. An assessment of the quality of evidence
revealed that articles were of high (n¼2), moderate (n¼14), low (n¼10)
and very low (n¼10) quality. Papers were grouped based on outcome
measures: disease/tissue markers, pain, self-reported physical function,
mobility performance, general health, and participation/quality of life.
Interventions reﬂected exercise (strengthening, walking, yoga, gaming),
physical agents and electrotherapy (ultrasound, phonophoresis, short
wave diathermy, transcutaneous electrical nerve stimulation, neuro-
muscular electrical stimulation), manual therapy (mobilizations, trac-
tion), Chinese medicine (acupuncture, meridians) and other (pain
coping, counseling, whole body vibration). High quality studies high-
lighted rehabilitation strategies that improved markers of OA disease
and general health, in addition to improvements in clinical outcomes,
over both the short term and long term. For example, in a randomized,
double-blind, controlled trial, phonophoresis was superior to tradi-
tional ultrasound for symptomatic knee OA in reducing pain over 2
weeks of therapy. A randomized controlled trial (n¼454) compared the
effectiveness of an intensive diet-induced weight-loss, exercise, or diet-
induced weight loss combinedwith exercise onmechanistic and clinical
outcomes in knee OA over a follow-up period of 6 and 18 months. After
18 months, data from 399 participants demonstrated that diet com-
bined with exercise and diet alone resulted in greater declines in body
